I presume from the PR that Eliquis hit all endpoints on an ITT basis; however, given the way JNJ and Bayer presented the Xarelto data, your question is a reasonable one to ask.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.